BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 18297364)

  • 1. SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression.
    Huang L; Gainkam LO; Caveliers V; Vanhove C; Keyaerts M; De Baetselier P; Bossuyt A; Revets H; Lahoutte T
    Mol Imaging Biol; 2008; 10(3):167-75. PubMed ID: 18297364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
    Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
    J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo detection of small tumour lesions by multi-pinhole SPECT applying a (99m)Tc-labelled nanobody targeting the Epidermal Growth Factor Receptor.
    Krüwel T; Nevoltris D; Bode J; Dullin C; Baty D; Chames P; Alves F
    Sci Rep; 2016 Feb; 6():21834. PubMed ID: 26912069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
    Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
    Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel multivalent (99m)Tc-labeled EG2-C4bpα antibody for targeting the epidermal growth factor receptor in tumor xenografts.
    Li C; Zhang Y; Wang L; Feng H; Xia X; Ma J; Yuan H; Gao B; Lan X
    Nucl Med Biol; 2015 Jun; 42(6):547-54. PubMed ID: 25779037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer.
    Evazalipour M; D'Huyvetter M; Tehrani BS; Abolhassani M; Omidfar K; Abdoli S; Arezumand R; Morovvati H; Lahoutte T; Muyldermans S; Devoogdt N
    Contrast Media Mol Imaging; 2014; 9(3):211-20. PubMed ID: 24700748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy.
    Gainkam LO; Keyaerts M; Caveliers V; Devoogdt N; Vanhove C; Van Grunsven L; Muyldermans S; Lahoutte T
    Mol Imaging Biol; 2011 Oct; 13(5):940-8. PubMed ID: 20865332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of a novel
    Jiao H; Zhao X; Han J; Zhang J; Wang J
    Int J Radiat Biol; 2020 Nov; 96(11):1443-1451. PubMed ID: 32809887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT.
    Vaneycken I; Govaert J; Vincke C; Caveliers V; Lahoutte T; De Baetselier P; Raes G; Bossuyt A; Muyldermans S; Devoogdt N
    J Nucl Med; 2010 Jul; 51(7):1099-106. PubMed ID: 20554727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
    Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
    J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive Evaluation of EGFR Expression of Digestive Tumors Using
    Shi D; Zhang Y; Xu Z; Si Z; Cheng Y; Cheng D; Liu G
    Mol Imaging; 2022; 2022():3748315. PubMed ID: 35903247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and preclinical evaluation of rhenium and technetium-99m "4 + 1" mixed-ligand complexes bearing quinazoline derivatives as potential EGFR imaging agents.
    Kiritsis C; Shegani A; Makrypidi K; Roupa I; Lazopoulos A; Panagiotopoulou A; Triantopoulou S; Paravatou-Petsotas M; Pietzsch HJ; Pelecanou M; Papadopoulos M; Pirmettis I
    Bioorg Med Chem; 2022 Nov; 73():117012. PubMed ID: 36155319
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Piramoon M; Hosseinimehr SJ; Omidfar K; Noaparast Z; Abedi SM
    Chem Biol Drug Des; 2017 Apr; 89(4):498-504. PubMed ID: 27650045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Radioimmune
    Ye M; Gai Y; Ji H; Jiang Y; Qiao P; Wang W; Zhang Y; Xia X; Lan X
    Front Immunol; 2021; 12():660842. PubMed ID: 34484174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation of [
    Liu T; Wu Y; Shi L; Li L; Hu B; Wang Y; Gao H; Yu X; Zhang X; Zhao H; Wan Y; Jia B; Wang F
    Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1810-1821. PubMed ID: 35013776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and Evaluation of (99m)Tc-Epidermal Growth Factor Receptor (EGFR)-Peptide Nucleic Acid for Visualization of EGFR Messenger RNA Expression in Malignant Tumors.
    Zhao X; Wang N; Ren X; Zhang J; Wang J; Han J; Jia L; Liu Y; Zhang Z
    J Nucl Med; 2014 Jun; 55(6):1008-16. PubMed ID: 24744447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and preclinical investigation of
    Shah SQ; Gul-E-Raana
    Mol Biol Rep; 2019 Apr; 46(2):1675-1682. PubMed ID: 30680596
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.